Contact our team

Why a Centralized Translation Source Matters for Biotech and Pharma IP

June 5, 2019

biotech and pharma intellectual propertyThe biotech and pharmaceutical industries both work at the cutting edge of science to deliver medical innovations to patients around the world. While the intellectual property portfolios of each industry vary widely, the path to obtaining strong IP protection is similar. To recoup R&D investment, both industries need to file their parents broadly and on a global scale, and that path includes extensive patent translations.

What’s the difference?

Biotech & pharma are often used interchangeably but it’s important to understand the distinction. Read more about: Why a Centralized Translation Source Matters for Biotech and Pharma IP  »

Groundbreaking Instant Quoting Tool for IP Translation & Filing

June 3, 2019

Morningside is excited to announce that IQ, the ground-breaking instant quoting feature on our IP Platform is now available for client use.

Designed specifically with our IP clients’ needs in mind, our secure, market-leading IP Platform streamlines and centralizes the patent translation & foreign patent filing process by letting you easily request quotes, place orders and manage IP projects all from one place.

Our newest feature, Read more about: Groundbreaking Instant Quoting Tool for IP Translation & Filing  »

Press Release: Morningside Acquires Life Science Language Services Leader Net-Translators

May 7, 2019

NEW YORK, NY – Morningside Translations, a Top 25 global provider of language services, recently acquired life sciences specialist Net-Translators. Headquartered near Tel Aviv, Israel, Net-Translators provides high-quality translation, localization and multilingual testing services to leading global medical device manufacturers, pharmaceutical companies, life science research organizations, and software developers.

The addition of Net-Translators dramatically expands Morningside’s global life sciences practice and significantly extends its life science reach across Europe, Read more about: Press Release: Morningside Acquires Life Science Language Services Leader Net-Translators  »

Infographic: 2019 Trends in IP Litigation

April 3, 2019

Innovation is on the rise, with a handful of industries — namely IT, telecom and life sciences — driving patent growth worldwide. According to WIPO, “Patents granted by the EPO grew by 40% in 2016 – the fastest growth since 1983.” In 2016, the Chinese patent grant rate increased by 13% and in Japan and Korea it rose by 7%. As the number of granted patents grows around the world, the number of IP litigation cases has also grown – Read more about: Infographic: 2019 Trends in IP Litigation  »

Corporations: Why You Need To Consolidate Your Third-Party Translation Costs

February 27, 2019

Corporate Consolidation It’s common practice for international corporations to employ an assortment of law firms to meet different local and regional legal needs. In doing so, a great deal of money is inevitably spent on legal translation services for cross-border or multi-country dealings.

Oftentimes, companies simply leave these legal translations to their outside counsel to handle. While this may seem the simplest solution, it actually forfeits an opportunity to simultaneously keep costs under control, Read more about: Corporations: Why You Need To Consolidate Your Third-Party Translation Costs  »